厄德里希-切斯特病心包积液中的肿瘤坏死因子-α在体外可促进内皮渗漏，英夫利昔单抗可对其进行中和。 - Suppr

Suppr

超能文献

TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.

作者信息

Ferrero Elisabetta, Belloni Daniela, Corti Angelo, Doglioni Claudio, Dagna Lorenzo, Ferrarini Marina

机构信息

Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, I-20132 Milano, Italy.

出版信息

Rheumatology (Oxford). 2014 Jan;53(1):198-200. doi: 10.1093/rheumatology/ket246. Epub 2013 Jul 26.

DOI:10.1093/rheumatology/ket246

PMID:23893523

Abstract

摘要

相似文献

TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.

Rheumatology (Oxford). 2014 Jan;53(1):198-200. doi: 10.1093/rheumatology/ket246. Epub 2013 Jul 26.

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.

J Clin Oncol. 2012 Oct 1;30(28):e286-90. doi: 10.1200/JCO.2012.41.9911. Epub 2012 Aug 6.

[Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].

Dtsch Med Wochenschr. 2011 Sep;136(39):1952-6. doi: 10.1055/s-0031-1286368. Epub 2011 Sep 20.

Unusual Case of Recurrent Pericardial Effusion　- Erdheim-Chester Disease.

Circ J. 2019 Jul 25;83(8):1762. doi: 10.1253/circj.CJ-18-1223. Epub 2019 Feb 6.

Incessant pericardial effusion in a 9 year old male responding to infliximab.

Cardiol Young. 2009 Aug;19(4):413-5. doi: 10.1017/S1047951109990229. Epub 2009 Jun 29.

Unmasked diabetes insipidus after pericardial drainage and biopsy for pericardial effusion in association with Erdheim-Chester disease.

J Thorac Cardiovasc Surg. 2008 Jul;136(1):217-8. doi: 10.1016/j.jtcvs.2008.03.005. Epub 2008 May 2.

Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.

Eur J Echocardiogr. 2010 Aug;11(7):E25. doi: 10.1093/ejechocard/jeq052. Epub 2010 Apr 20.

Erdheim-Chester disease presenting with large pericardial effusion: a mimic of disseminated malignancy.

Intern Med J. 2011 Mar;41(3):291-3. doi: 10.1111/j.1445-5994.2011.02425.x.

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Front Immunol. 2018 Jun 1;9:1233. doi: 10.3389/fimmu.2018.01233. eCollection 2018.

Recurrent pericardial effusion and tamponade in a patient with Erdheim-Chester disease (ECD).

BMJ Case Rep. 2015 Nov 24;2015:bcr2015212483. doi: 10.1136/bcr-2015-212483.

引用本文的文献

The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.

Leukemia. 2025 Feb;39(2):516-519. doi: 10.1038/s41375-024-02459-5. Epub 2024 Nov 8.

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Front Immunol. 2018 Jun 1;9:1233. doi: 10.3389/fimmu.2018.01233. eCollection 2018.

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.

Oncoimmunology. 2016 May 5;5(7):e1181244. doi: 10.1080/2162402X.2016.1181244. eCollection 2016 Jul.

Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease.

Orphanet J Rare Dis. 2016 Aug 2;11(1):109. doi: 10.1186/s13023-016-0490-3.

Erdheim-Chester disease: from palliative care to targeted treatment.

Clin Kidney J. 2014 Aug;7(4):339-43. doi: 10.1093/ckj/sfu068. Epub 2014 Jul 15.

Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease.

Front Immunol. 2014 Jun 13;5:281. doi: 10.3389/fimmu.2014.00281. eCollection 2014.

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.

Erdheim-Chester Disease: a comprehensive review of the literature.

Orphanet J Rare Dis. 2013 Sep 8;8:137. doi: 10.1186/1750-1172-8-137.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.

作者信息

Ferrero Elisabetta, Belloni Daniela, Corti Angelo, Doglioni Claudio, Dagna Lorenzo, Ferrarini Marina

机构信息

Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, I-20132 Milano, Italy.

出版信息

Rheumatology (Oxford). 2014 Jan;53(1):198-200. doi: 10.1093/rheumatology/ket246. Epub 2013 Jul 26.

DOI:10.1093/rheumatology/ket246

PMID:23893523

Abstract

摘要

相似文献

TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.

Rheumatology (Oxford). 2014 Jan;53(1):198-200. doi: 10.1093/rheumatology/ket246. Epub 2013 Jul 26.

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.

J Clin Oncol. 2012 Oct 1;30(28):e286-90. doi: 10.1200/JCO.2012.41.9911. Epub 2012 Aug 6.

[Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].

Dtsch Med Wochenschr. 2011 Sep;136(39):1952-6. doi: 10.1055/s-0031-1286368. Epub 2011 Sep 20.

Unusual Case of Recurrent Pericardial Effusion　- Erdheim-Chester Disease.

Circ J. 2019 Jul 25;83(8):1762. doi: 10.1253/circj.CJ-18-1223. Epub 2019 Feb 6.

Incessant pericardial effusion in a 9 year old male responding to infliximab.

Cardiol Young. 2009 Aug;19(4):413-5. doi: 10.1017/S1047951109990229. Epub 2009 Jun 29.

Unmasked diabetes insipidus after pericardial drainage and biopsy for pericardial effusion in association with Erdheim-Chester disease.

J Thorac Cardiovasc Surg. 2008 Jul;136(1):217-8. doi: 10.1016/j.jtcvs.2008.03.005. Epub 2008 May 2.

Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.

Eur J Echocardiogr. 2010 Aug;11(7):E25. doi: 10.1093/ejechocard/jeq052. Epub 2010 Apr 20.

Erdheim-Chester disease presenting with large pericardial effusion: a mimic of disseminated malignancy.

Intern Med J. 2011 Mar;41(3):291-3. doi: 10.1111/j.1445-5994.2011.02425.x.

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Front Immunol. 2018 Jun 1;9:1233. doi: 10.3389/fimmu.2018.01233. eCollection 2018.

Recurrent pericardial effusion and tamponade in a patient with Erdheim-Chester disease (ECD).

BMJ Case Rep. 2015 Nov 24;2015:bcr2015212483. doi: 10.1136/bcr-2015-212483.

引用本文的文献

The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.

Leukemia. 2025 Feb;39(2):516-519. doi: 10.1038/s41375-024-02459-5. Epub 2024 Nov 8.

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Front Immunol. 2018 Jun 1;9:1233. doi: 10.3389/fimmu.2018.01233. eCollection 2018.

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.

Oncoimmunology. 2016 May 5;5(7):e1181244. doi: 10.1080/2162402X.2016.1181244. eCollection 2016 Jul.

Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease.

Orphanet J Rare Dis. 2016 Aug 2;11(1):109. doi: 10.1186/s13023-016-0490-3.

Erdheim-Chester disease: from palliative care to targeted treatment.

Clin Kidney J. 2014 Aug;7(4):339-43. doi: 10.1093/ckj/sfu068. Epub 2014 Jul 15.

Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease.

Front Immunol. 2014 Jun 13;5:281. doi: 10.3389/fimmu.2014.00281. eCollection 2014.

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.

Erdheim-Chester Disease: a comprehensive review of the literature.

Orphanet J Rare Dis. 2013 Sep 8;8:137. doi: 10.1186/1750-1172-8-137.